BlackRock’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $48.9K | Hold |
16,797
| – | – | ﹤0.01% | 4920 |
|
2025
Q1 | $42K | Hold |
16,797
| – | – | ﹤0.01% | 4903 |
|
2024
Q4 | $54.1K | Hold |
16,797
| – | – | ﹤0.01% | 4875 |
|
2024
Q3 | $43.5K | Sell |
16,797
-372
| -2% | -$963 | ﹤0.01% | 4789 |
|
2024
Q2 | $39.5K | Hold |
17,169
| – | – | ﹤0.01% | 4856 |
|
2024
Q1 | $54.9K | Hold |
17,169
| – | – | ﹤0.01% | 4792 |
|
2023
Q4 | $57.5K | Sell |
17,169
-831
| -5% | -$2.78K | ﹤0.01% | 4867 |
|
2023
Q3 | $61.6K | Hold |
18,000
| – | – | ﹤0.01% | 4898 |
|
2023
Q2 | $74.2K | Sell |
18,000
-1
| -0% | -$4 | ﹤0.01% | 4911 |
|
2023
Q1 | $156K | Sell |
18,001
-14
| -0.1% | -$121 | ﹤0.01% | 4762 |
|
2022
Q4 | $236K | Sell |
18,015
-19
| -0.1% | -$249 | ﹤0.01% | 4720 |
|
2022
Q3 | $310K | Sell |
18,034
-45
| -0.2% | -$774 | ﹤0.01% | 4770 |
|
2022
Q2 | $198K | Sell |
18,079
-3,990
| -18% | -$43.7K | ﹤0.01% | 4940 |
|
2022
Q1 | $490K | Sell |
22,069
-189
| -0.8% | -$4.2K | ﹤0.01% | 4783 |
|
2021
Q4 | $765K | Buy |
22,258
+500
| +2% | +$17.2K | ﹤0.01% | 4674 |
|
2021
Q3 | $1.34M | Sell |
21,758
-49
| -0.2% | -$3.01K | ﹤0.01% | 4416 |
|
2021
Q2 | $1.7M | Sell |
21,807
-62,467
| -74% | -$4.87M | ﹤0.01% | 4275 |
|
2021
Q1 | $4.7M | Buy |
84,274
+4,068
| +5% | +$227K | ﹤0.01% | 3908 |
|
2020
Q4 | $4.91M | Buy |
80,206
+4,039
| +5% | +$247K | ﹤0.01% | 3646 |
|
2020
Q3 | $9.26M | Sell |
76,167
-2,176
| -3% | -$265K | ﹤0.01% | 3181 |
|
2020
Q2 | $9.26M | Sell |
78,343
-1,120
| -1% | -$132K | ﹤0.01% | 3161 |
|
2020
Q1 | $4.21M | Sell |
79,463
-1,371
| -2% | -$72.7K | ﹤0.01% | 3365 |
|
2019
Q4 | $4.4M | Buy |
80,834
+5,361
| +7% | +$292K | ﹤0.01% | 3497 |
|
2019
Q3 | $18.3M | Buy |
75,473
+1,586
| +2% | +$384K | ﹤0.01% | 2835 |
|
2019
Q2 | $16.9M | Buy |
+73,887
| New | +$16.9M | ﹤0.01% | 2910 |
|